Pulse Biosciences Inc
General ticker "PLSE" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $1.2B
Pulse Biosciences Inc follows the US Stock Market performance with the rate: 55.8%.
Estimated limits based on current volatility of 5.0%: low 17.35$, high 19.18$
Factors to consider:
- North America accounted for 73.9% of revenue in the fiscal year ended 2022-12-31
- Current price 10.4% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [6.41$, 15.75$]
- 2024-12-30 to 2025-12-30 estimated range: [4.12$, 11.01$]
Financial Metrics affecting the PLSE estimates:
- Negative: Non-GAAP EPS, $ of -0.72 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -6.39 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Negative: Industry earnings per price (median), % of -6.44 <= 1.31
Short-term PLSE quotes
Long-term PLSE plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $1.42MM | $0.70MM | $0.00MM |
| Operating Expenses | $64.43MM | $58.76MM | $43.57MM |
| Operating Income | $-63.01MM | $-58.06MM | $-43.57MM |
| Non-Operating Income | $-0.65MM | $-0.45MM | $1.36MM |
| Interest Expense | $0.65MM | $0.45MM | $0.00MM |
| R&D Expense | $28.64MM | $20.84MM | $27.80MM |
| Income(Loss) | $-63.66MM | $-58.51MM | $-42.21MM |
| Profit(Loss) | $-63.66MM | $-58.51MM | $-42.21MM |
| Stockholders Equity | $35.69MM | $-2.25MM | $44.36MM |
| Inventory | $5.82MM | $0.00MM | $0.00MM |
| Assets | $54.25MM | $77.88MM | $59.15MM |
| Operating Cash Flow | $-54.10MM | $-47.01MM | $-33.04MM |
| Capital expenditure | $0.44MM | $0.40MM | $0.12MM |
| Investing Cash Flow | $7.56MM | $-0.40MM | $-0.12MM |
| Financing Cash Flow | $62.69MM | $79.94MM | $16.39MM |
| Earnings Per Share* | $-2.26 | $-1.74 | $-0.88 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.